Medline Shareholders to Sell 75 Million Shares Amid Stock Rally

Medline shareholders are set to sell 75 million shares as the company's stock experiences a significant rally since its debut late last year. Bloomberg posted on X, highlighting the move as shareholders aim to capitalize on the increased stock value. The medical supplier has seen a surge in its stock price, prompting this substantial offering. The decision reflects confidence in the company's market performance and the potential for continued growth.